Elizabeth H. Cull

Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death

Jessica K. Altman, Alfred Rademaker, Elizabeth H. Cull et al. · Leukemia Research · 2013 · 134 citations

Medicine, Hematology, Oncology +11

A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Fatih M. Uckun, Tara L. Lin, Alice S. Mims et al. · Cancers · 2021 · 43 citations · Full text

Medicine, Hematology, Pharmacology +17

Phase 1/1b Study of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, As Monotherapy or in Combination with Cytarabine for the Treatment of Relapsed/Refractory AML and Advanced MDS with TP53 Wild-Type

David A. Sallman, Uma Borate, Elizabeth H. Cull et al. · Blood · 2018 · 32 citations

Medicine, Pharmacology, Pharmacotherapy +11

Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies in a patient with infectious mononucleosis

Elizabeth H. Cull, Brady L. Stein · International Journal of Hematology · 2012 · 19 citations

Life Sciences, Hematology, Immunology +13

Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma

Ahmad Halwani, Carlos Panizo, Iris Isufi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2021 · 18 citations

Medicine, Oncology, Pharmacology +17